Development of quality measures for the care of patients withgastroesophageal reflux disease

Rena Yadlapati, Andrew J. Gawron, Karl Bilimoria, Rajesh N. Keswani, Kerry B. Dunbar, Peter J. Kahrilas, Philip Katz, Joel Richter, Felice Schnoll-Sussman, Nathaniel Soper, Marcelo F. Vela, John E. Pandolfino

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background & Aims: Gastroesophageal reflux disease (GERD) is a common and costly disorder. Symptoms attributed to GERD have a wide spectrum of presentations and complications that have led to complex diagnostic and management algorithms. As such, there is considerable variation in clinical approaches to GERD. In contrast to multiple published guidelines for the management of GERD, there are few validated GERD quality measures. The objective of this study was to use a well-described, formal methodology to develop valid, physician-led quality measures for all aspects of care for patients with GERD. Methods: Quality measures were identified from the literature, consensus guidelines, and GERD experts. Eight clinical experts ranked potential measures for validity on the basis of the RAND/Universityof California, Los Angeles Appropriateness Methodology. Results: Of the 52 proposed quality measures, 24 were rated as valid, and 1 new measure was developed. These valid measures were related to initial diagnosis and management (9), monitoring (3), further diagnostic testing (4), proton pump inhibitor refractory symptoms (2), symptoms of chest pain (1), erosive esophagitis (3), esophageal stricture or ring (1), and surgical therapy (2). Fifteen of these measures were ranked with the highest validity. Twenty-seven measures were determined to be equivocal; 89% of these were extracted from guidelines that were based on low or moderate level evidence. Conclusions: We used RAND/University of California, Los Angeles Appropriateness Methodology to develop quality measures for GERD care. By examining performance on these valid, formally developed quality measures, clinical practices and individual providers can assess their adherence with them and direct quality improvement efforts accordingly.

Original languageEnglish (US)
Pages (from-to)874-883
Number of pages10
JournalClinical Gastroenterology and Hepatology
Volume13
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Quality of Health Care
Gastroesophageal Reflux
Los Angeles
Guidelines
Esophageal Stenosis
Esophagitis
Proton Pump Inhibitors
Quality Improvement
Chest Pain
Patient Care
Physicians

Keywords

  • Gastroesophageal reflux disease (GERD)
  • Measure of quality of care
  • Proton pump inhibitor (PPI)
  • RAND/UCLA appropriateness methodology (RAM)

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Yadlapati, R., Gawron, A. J., Bilimoria, K., Keswani, R. N., Dunbar, K. B., Kahrilas, P. J., ... Pandolfino, J. E. (2015). Development of quality measures for the care of patients withgastroesophageal reflux disease. Clinical Gastroenterology and Hepatology, 13(5), 874-883. https://doi.org/10.1016/j.cgh.2014.11.012

Development of quality measures for the care of patients withgastroesophageal reflux disease. / Yadlapati, Rena; Gawron, Andrew J.; Bilimoria, Karl; Keswani, Rajesh N.; Dunbar, Kerry B.; Kahrilas, Peter J.; Katz, Philip; Richter, Joel; Schnoll-Sussman, Felice; Soper, Nathaniel; Vela, Marcelo F.; Pandolfino, John E.

In: Clinical Gastroenterology and Hepatology, Vol. 13, No. 5, 01.05.2015, p. 874-883.

Research output: Contribution to journalArticle

Yadlapati, R, Gawron, AJ, Bilimoria, K, Keswani, RN, Dunbar, KB, Kahrilas, PJ, Katz, P, Richter, J, Schnoll-Sussman, F, Soper, N, Vela, MF & Pandolfino, JE 2015, 'Development of quality measures for the care of patients withgastroesophageal reflux disease', Clinical Gastroenterology and Hepatology, vol. 13, no. 5, pp. 874-883. https://doi.org/10.1016/j.cgh.2014.11.012
Yadlapati, Rena ; Gawron, Andrew J. ; Bilimoria, Karl ; Keswani, Rajesh N. ; Dunbar, Kerry B. ; Kahrilas, Peter J. ; Katz, Philip ; Richter, Joel ; Schnoll-Sussman, Felice ; Soper, Nathaniel ; Vela, Marcelo F. ; Pandolfino, John E. / Development of quality measures for the care of patients withgastroesophageal reflux disease. In: Clinical Gastroenterology and Hepatology. 2015 ; Vol. 13, No. 5. pp. 874-883.
@article{21c7ca52fa644ee5be1f1873d5f01613,
title = "Development of quality measures for the care of patients withgastroesophageal reflux disease",
abstract = "Background & Aims: Gastroesophageal reflux disease (GERD) is a common and costly disorder. Symptoms attributed to GERD have a wide spectrum of presentations and complications that have led to complex diagnostic and management algorithms. As such, there is considerable variation in clinical approaches to GERD. In contrast to multiple published guidelines for the management of GERD, there are few validated GERD quality measures. The objective of this study was to use a well-described, formal methodology to develop valid, physician-led quality measures for all aspects of care for patients with GERD. Methods: Quality measures were identified from the literature, consensus guidelines, and GERD experts. Eight clinical experts ranked potential measures for validity on the basis of the RAND/Universityof California, Los Angeles Appropriateness Methodology. Results: Of the 52 proposed quality measures, 24 were rated as valid, and 1 new measure was developed. These valid measures were related to initial diagnosis and management (9), monitoring (3), further diagnostic testing (4), proton pump inhibitor refractory symptoms (2), symptoms of chest pain (1), erosive esophagitis (3), esophageal stricture or ring (1), and surgical therapy (2). Fifteen of these measures were ranked with the highest validity. Twenty-seven measures were determined to be equivocal; 89{\%} of these were extracted from guidelines that were based on low or moderate level evidence. Conclusions: We used RAND/University of California, Los Angeles Appropriateness Methodology to develop quality measures for GERD care. By examining performance on these valid, formally developed quality measures, clinical practices and individual providers can assess their adherence with them and direct quality improvement efforts accordingly.",
keywords = "Gastroesophageal reflux disease (GERD), Measure of quality of care, Proton pump inhibitor (PPI), RAND/UCLA appropriateness methodology (RAM)",
author = "Rena Yadlapati and Gawron, {Andrew J.} and Karl Bilimoria and Keswani, {Rajesh N.} and Dunbar, {Kerry B.} and Kahrilas, {Peter J.} and Philip Katz and Joel Richter and Felice Schnoll-Sussman and Nathaniel Soper and Vela, {Marcelo F.} and Pandolfino, {John E.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.cgh.2014.11.012",
language = "English (US)",
volume = "13",
pages = "874--883",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Development of quality measures for the care of patients withgastroesophageal reflux disease

AU - Yadlapati, Rena

AU - Gawron, Andrew J.

AU - Bilimoria, Karl

AU - Keswani, Rajesh N.

AU - Dunbar, Kerry B.

AU - Kahrilas, Peter J.

AU - Katz, Philip

AU - Richter, Joel

AU - Schnoll-Sussman, Felice

AU - Soper, Nathaniel

AU - Vela, Marcelo F.

AU - Pandolfino, John E.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Background & Aims: Gastroesophageal reflux disease (GERD) is a common and costly disorder. Symptoms attributed to GERD have a wide spectrum of presentations and complications that have led to complex diagnostic and management algorithms. As such, there is considerable variation in clinical approaches to GERD. In contrast to multiple published guidelines for the management of GERD, there are few validated GERD quality measures. The objective of this study was to use a well-described, formal methodology to develop valid, physician-led quality measures for all aspects of care for patients with GERD. Methods: Quality measures were identified from the literature, consensus guidelines, and GERD experts. Eight clinical experts ranked potential measures for validity on the basis of the RAND/Universityof California, Los Angeles Appropriateness Methodology. Results: Of the 52 proposed quality measures, 24 were rated as valid, and 1 new measure was developed. These valid measures were related to initial diagnosis and management (9), monitoring (3), further diagnostic testing (4), proton pump inhibitor refractory symptoms (2), symptoms of chest pain (1), erosive esophagitis (3), esophageal stricture or ring (1), and surgical therapy (2). Fifteen of these measures were ranked with the highest validity. Twenty-seven measures were determined to be equivocal; 89% of these were extracted from guidelines that were based on low or moderate level evidence. Conclusions: We used RAND/University of California, Los Angeles Appropriateness Methodology to develop quality measures for GERD care. By examining performance on these valid, formally developed quality measures, clinical practices and individual providers can assess their adherence with them and direct quality improvement efforts accordingly.

AB - Background & Aims: Gastroesophageal reflux disease (GERD) is a common and costly disorder. Symptoms attributed to GERD have a wide spectrum of presentations and complications that have led to complex diagnostic and management algorithms. As such, there is considerable variation in clinical approaches to GERD. In contrast to multiple published guidelines for the management of GERD, there are few validated GERD quality measures. The objective of this study was to use a well-described, formal methodology to develop valid, physician-led quality measures for all aspects of care for patients with GERD. Methods: Quality measures were identified from the literature, consensus guidelines, and GERD experts. Eight clinical experts ranked potential measures for validity on the basis of the RAND/Universityof California, Los Angeles Appropriateness Methodology. Results: Of the 52 proposed quality measures, 24 were rated as valid, and 1 new measure was developed. These valid measures were related to initial diagnosis and management (9), monitoring (3), further diagnostic testing (4), proton pump inhibitor refractory symptoms (2), symptoms of chest pain (1), erosive esophagitis (3), esophageal stricture or ring (1), and surgical therapy (2). Fifteen of these measures were ranked with the highest validity. Twenty-seven measures were determined to be equivocal; 89% of these were extracted from guidelines that were based on low or moderate level evidence. Conclusions: We used RAND/University of California, Los Angeles Appropriateness Methodology to develop quality measures for GERD care. By examining performance on these valid, formally developed quality measures, clinical practices and individual providers can assess their adherence with them and direct quality improvement efforts accordingly.

KW - Gastroesophageal reflux disease (GERD)

KW - Measure of quality of care

KW - Proton pump inhibitor (PPI)

KW - RAND/UCLA appropriateness methodology (RAM)

UR - http://www.scopus.com/inward/record.url?scp=84927911166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927911166&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2014.11.012

DO - 10.1016/j.cgh.2014.11.012

M3 - Article

VL - 13

SP - 874

EP - 883

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 5

ER -